- Home
- Companies
- micronesia
- spike protein
Refine by
Spike Protein Suppliers Near Micronesia
35 companies found
based inBurlingame, CALIFORNIA (USA)
Using our vast experience, we were able to synthesize the human AGRP (83-1321) NH2 peptide. This product proved to be a potent inhibitor of MC3-R and MC4-R function. Another innovation tor Phoenix Pharmaceuticals, as we were first-to-market with ...
Molecular Weight: 5752.52, Purity: ≥ 90%, Validation: Exhibits correct molecular weight, Storage: Up to 6 months in lyophilized form at 0-5ºC. For best results, rehydrate just before use. After rehydration, keep solution at +4ºC for up ...
based inTainan City, TAIWAN
Leadgene Biomedical Inc. is founded in 2013 and headquarters in Tainan, Taiwan. In the past years, we have become an all-around solution provider for proteomics study with more than thirty staff members from a three-scientists workshop, ...
SARS-CoV-2 virus-like particles B1.351 (Beta) are composed of four structural proteins: Membrane protein (M), Nucleocapsid protein (N), Beta-spike protein (S) ...
based inPeachtree Corners, GEORGIA (US) (USA)
RayBiotech is a leading life sciences company providing proteomic discovery tools. RayBiotech has nearly 150 employees whose objectives are to provide excellent products and service worldwide to RayBiotech customers which include scientists in ...
The SARS-CoV-2 Spike Protein Overlapping Peptide Array is semi-quantitative array displaying 316 synthesized peptides representing the full-length SARS-CoV-2 Spike protein ...
based inPaoli, NEW JERSEY (USA)
Beta Lifescience is a professional biotech company committed to providing premium quality life science research reagents worldwide across research and diagnostic markets. Our strong portfolio of recombinant proteins, viral antigens, antibodies, ...
Anti-Spike RBD Protein of SARS-CoV-2 (2019-nCoV/Wuhan), Mouse Monoclonal ...
based inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
The COVI-QUANT™ test will give you an answer. It represents the latest generation of testing technology that will provide a numerical value for your antibody level, not just yes or no. COVI-QUANT™ is an ELISA test available through ...
based inWest Sacramento, CALIFORNIA (USA)
We founded Molecular Matrix in 2011. After seven years of rigorous research and development on our tissue regeneration technology, we received FDA clearance for our breakthrough bone regeneration medical device. We believe that medicine is a ...
Test for antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19. This is the only FDA EUA approved test to determine whether you have functional neutralizing antibodies. Other IgG/IgM antibody tests do not provide results on the ...
based inBalerna, SWITZERLAND
PRIMA Lab SA, modern Swiss Company in the diagnostic field, develops the core of its innovation offering simple and efficient devices CE certified, for a quick check-up of human and animal’s health conditions. Thanks to its complete range of tests, ...
COVID-19 Neutralising IgG Serological Test is a rapid device which verifies the presence of COVID-19 neutralising IgG antibodies in human blood samples produced after the end of the vaccination cycle. ...
based inExeter, UNITED KINGDOM
Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been ...
The following single-chip panels are available for the Liscar 6 platform. Additional panels will be highlighted here as they come on stream so please check back regularly or get in touch so that we can notify you when new panels are released. ...
based inSALUGGIA, ITALY
We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the ...
DiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated ...
based inShanghai City, CHINA
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma'; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates ...
Messenger ribonucleic acid (mRNA) vaccines are a novel technology that stimulate the body’s own immune response. These vaccines contain information from messenger RNA, including the “blueprint” or code of a specific virus trait ...
based inStanmore, UNITED KINGDOM
Acellera’s mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning. In order to fulfill this vision, we work with our customers by becoming a key technology partner, boosting their ...
based inHercules, CALIFORNIA (USA)
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products ...
Reduce Lead Time for Antibody Generation: Assays supporting SARS-CoV-2 vaccine, therapeutic, and diagnostic test development must be robust, scalable, and transferable to laboratories worldwide. They need to be designed and validated rapidly, yet ...
based inRedwood City, CALIFORNIA (USA)
Meissa Vaccines was founded with a mission to protect people everywhere from deadly respiratory viruses and a commitment to develop innovative technologies capable of delivering effective vaccines at a global scale. Meissa is developing live ...
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and ...
based inKAARINA, FINLAND
Labmaster Oy Ltd. is a company engaged in the design, development, and manufacturing of various products, ensuring they meet specified criteria through proper storage, usage, and transportation guidelines. They emphasize adherence to instructions ...
The Labmaster LUCIA™ SARS-CoV-2 IgG RBD test is meant for in vitro diagnostic qualitative detection of the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptor Binding Domain IgG antibodies from whole blood samples ...
based inRoswell, GEORGIA (US) (USA)
OPTI Medical Systems, a subsidiary of IDEXX Laboratories, Inc., is an international and fast-growing diagnostics business with operations in Atlanta, Georgia, USA, serving the high-growth, near-patient testing market, targeting small- to ...
The OPTI SARS-CoV-2 Total Antibody Test is an enzyme-linked immunosorbent assay (ELISA) that detects total antibodies (IgG, IgM, and IgA) against the receptor binding domain (RBD) of the spike (S) protein of ...
based inLich, GERMANY
Since 1947, however, our desire to inspire you by understanding your needs has been even more central. Which is why we strive to develop only products with added value and meaning. This is where decades of experience and innovations flow in, ...
Fast detection of variants? With our clever real-time ViroQ® SC2 Variant 1 / Variant 2 and Variant 3 kits you can react quickly to variants of the SARS-CoV-2 virus of origin. In contrast to gene-seqeuncing, which takes about 30 hours, the ...
based inGeumcheon-gu, SOUTH KOREA
Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R&D works and testing ...
The SARS-CoV-2 variants can not only interrupt the formation of herd immunity through vaccination, but also the prevention and efficacy of the medical treatment. ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
based inMunich, GERMANY
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide european-wide support in medical & clinical trial development for therapeutics and ...
The acute SARS-CoV-2 infection is diagnosed routinely through PCR-based detection of viral RNA from nasopharyngeal swabs. Additionally, direct antigen detection of viral proteins is now available. The specific detection by PCR has a high sensitivity ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
VIRALEZE™ is an antiviral nasal spray that contains astodrimer sodium (SPL7013), which has been shown in laboratory studies to inactivate a broad spectrum of respiratory viruses, including >99.9% of coronavirus SARS-CoV-2, the virus that ...
